• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在近期发作关节炎的第一年随访中是否应重新评估抗瓜氨酸化蛋白抗体和类风湿因子状态?一项纵向研究。

Should anti-citrullinated protein antibody and rheumatoid factor status be reassessed during the first year of followup in recent-onset arthritis? A longitudinal study.

机构信息

Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.

出版信息

J Rheumatol. 2011 Nov;38(11):2336-41. doi: 10.3899/jrheum.110234. Epub 2011 Oct 1.

DOI:10.3899/jrheum.110234
PMID:21965645
Abstract

OBJECTIVE

Presence and levels of antibodies contribute to the classification of rheumatoid arthritis. We investigated the longitudinal course of anti-citrullinated protein antibodies (ACPA) and immunoglobin M (IgM) rheumatoid factor (RF) during the first year after arthritis onset in patients with very short disease duration.

METHODS

Patients (aged 18-75 years) with ≥ 1 swollen joint of ≤ 16 weeks' duration had assessments of ACPA (2nd generation anti-cyclic citrullinated peptide antibodies, anti-CCP2) and IgM RF at inclusion and after 3, 6, and 12 months. Frequencies of seroconversions (negative to positive and vice versa) and changes in antibody levels during followup were determined.

RESULTS

A total of 281 early arthritis patients (median duration of joint swelling 32 days, 14.2% ACPA positives, 12.8% IgM RF positives) with 978 longitudinally collected serum samples were included. Only 5 patients (1.8%) negative for both antibodies at baseline turned antibody-positive during followup, while 9 antibody-positive patients (3.2%) turned antibody-negative. ACPA was more stable than RF regarding both status and levels.

CONCLUSION

Antibody status (ACPA/RF) is a stable phenotype in very early arthritis, as seroconversion was only found in 5% of patients. Repeated measurement of ACPA or RF during the first year after onset of arthritis does not offer major additional information.

摘要

目的

抗体的存在和水平有助于类风湿关节炎的分类。我们研究了疾病持续时间非常短的关节炎患者在发病后 1 年内抗瓜氨酸化蛋白抗体(ACPA)和免疫球蛋白 M(IgM)类风湿因子(RF)的纵向变化过程。

方法

≥1 个关节肿胀≤16 周的 18-75 岁患者在纳入时和 3、6 和 12 个月时进行 ACPA(第二代抗环瓜氨酸肽抗体,抗-CCP2)和 IgM RF 评估。确定随访期间的血清转换(由阴转阳和由阳转阴)频率以及抗体水平的变化。

结果

共纳入 281 例早期关节炎患者(关节肿胀中位数为 32 天,14.2%的患者 ACPA 阳性,12.8%的患者 IgM RF 阳性),共采集了 978 份纵向采集的血清样本。仅 5 名基线时两种抗体均阴性的患者在随访期间转为阳性,而 9 名抗体阳性患者(3.2%)转为阴性。在非常早期的关节炎中,抗体状态(ACPA/RF)是一种稳定的表型,因为只有 5%的患者发生血清转换。在关节炎发病后 1 年内重复测量 ACPA 或 RF 并不能提供更多的信息。

相似文献

1
Should anti-citrullinated protein antibody and rheumatoid factor status be reassessed during the first year of followup in recent-onset arthritis? A longitudinal study.在近期发作关节炎的第一年随访中是否应重新评估抗瓜氨酸化蛋白抗体和类风湿因子状态?一项纵向研究。
J Rheumatol. 2011 Nov;38(11):2336-41. doi: 10.3899/jrheum.110234. Epub 2011 Oct 1.
2
Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis.抗环瓜氨酸肽2(Anti-CCP2)在类风湿关节炎诊断中是类风湿因子的辅助指标而非替代指标:抗CCP2抗体在埃及类风湿关节炎患者中的诊断效用
Scand J Rheumatol. 2008 Sep-Oct;37(5):329-36. doi: 10.1080/03009740802116208.
3
Anticitrullinated protein antibodies and rheumatoid factor fluctuate in early inflammatory arthritis and do not predict clinical outcomes.抗瓜氨酸化蛋白抗体和类风湿因子在早期炎症性关节炎中波动,不能预测临床结局。
J Rheumatol. 2013 Aug;40(8):1259-67. doi: 10.3899/jrheum.120736. Epub 2013 Feb 1.
4
Antibodies to porphyromonas gingivalis are associated with anticitrullinated protein antibodies in patients with rheumatoid arthritis and their relatives.牙龈卟啉单胞菌抗体与类风湿关节炎患者及其亲属的抗瓜氨酸化蛋白抗体相关。
J Rheumatol. 2010 Jun;37(6):1105-12. doi: 10.3899/jrheum.091323. Epub 2010 May 1.
5
Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study.关节痛患者的关节炎发展与抗瓜氨酸化蛋白抗体状态密切相关:一项前瞻性队列研究。
Ann Rheum Dis. 2010 Mar;69(3):490-4. doi: 10.1136/ard.2008.105759. Epub 2009 Apr 9.
6
Prognosis of seronegative patients in a large prospective cohort of patients with early inflammatory arthritis.早期炎症性关节炎患者大型前瞻性队列中血清学阴性患者的预后
J Rheumatol. 2014 Dec;41(12):2361-9. doi: 10.3899/jrheum.140082. Epub 2014 Oct 1.
7
Repeated anticitrullinated protein antibody and rheumatoid factor assessment is not necessary in early arthritis: results from the ESPOIR cohort.在早期关节炎中,重复检测抗瓜氨酸化蛋白抗体和类风湿因子并非必要:来自 ESPOIR 队列的结果。
J Rheumatol. 2014 Jan;41(1):41-6. doi: 10.3899/jrheum.121313. Epub 2013 Nov 15.
8
Differential response of the rheumatoid factor and anticitrullinated protein antibodies during adalimumab treatment in patients with rheumatoid arthritis.类风湿关节炎患者在接受阿达木单抗治疗期间类风湿因子和抗瓜氨酸化蛋白抗体的差异反应。
J Rheumatol. 2008 Oct;35(10):1972-7. Epub 2008 Sep 1.
9
[Diagnostic performance of anti-cyclic citrullinated antibodies and IgM rheumatoid factor in rheumatoid arthritis].抗环瓜氨酸化抗体和 IgM 类风湿因子在类风湿关节炎中的诊断效能
Acta Reumatol Port. 2007 Oct-Dec;32(4):345-9.
10
Association of rheumatoid arthritis treatment response and disease duration with declines in serum levels of IgM rheumatoid factor and anti-cyclic citrullinated peptide antibody.类风湿关节炎治疗反应及病程与血清 IgM 类风湿因子和抗环瓜氨酸肽抗体水平下降的关联
Arthritis Rheum. 2004 Dec;50(12):3776-82. doi: 10.1002/art.20659.

引用本文的文献

1
Autoantibodies as prognostic markers in rheumatoid arthritis.自身抗体作为类风湿关节炎的预后标志物
J Transl Autoimmun. 2025 May 3;10:100291. doi: 10.1016/j.jtauto.2025.100291. eCollection 2025 Jun.
2
Rheumatoid factor and falsely elevated results in commercial immunoassays: data from an early arthritis cohort.类风湿因子与商业免疫测定中的假阳性结果:来自早期关节炎队列的数据。
Rheumatol Int. 2021 Sep;41(9):1657-1665. doi: 10.1007/s00296-021-04865-9. Epub 2021 May 4.
3
ROS-Dependent Lipid Peroxidation and Reliant Antioxidant Ferroptosis-Suppressor-Protein 1 in Rheumatoid Arthritis: a Covert Clue for Potential Therapy.
ROS 依赖性脂质过氧化作用及依赖的抗氧化剂铁死亡抑制蛋白 1 在类风湿关节炎中的作用:潜在治疗的潜在线索。
Inflammation. 2021 Feb;44(1):35-47. doi: 10.1007/s10753-020-01338-2. Epub 2020 Sep 12.
4
Readability of patient information and consent documents in rheumatological studies.风湿病学研究中患者信息及同意书的可读性
BMC Med Ethics. 2016 Jul 16;17(1):42. doi: 10.1186/s12910-016-0126-0.
5
Improved serological detection of rheumatoid arthritis: a highly antigenic mimotope of carbonic anhydrase III selected in a murine model by phage display.类风湿关节炎血清学检测的改进:通过噬菌体展示在小鼠模型中筛选出的碳酸酐酶III的高抗原性模拟表位
Arthritis Res Ther. 2015 Jun 23;17(1):168. doi: 10.1186/s13075-015-0685-3.
6
Rheumatoid factor and anti-citrullinated protein antibody positivity, but not level, are associated with increased mortality in patients with rheumatoid arthritis: results from two large independent cohorts.类风湿因子和抗瓜氨酸化蛋白抗体呈阳性而非其水平,与类风湿关节炎患者死亡率增加相关:两项大型独立队列研究结果
Arthritis Res Ther. 2014 Dec 4;16(6):483. doi: 10.1186/s13075-014-0483-3.
7
Predictive value of anti-citrullinated peptide antibodies: a real life experience.抗瓜氨酸化肽抗体的预测价值:实际应用经验
Immunol Res. 2014 Dec;60(2-3):348-55. doi: 10.1007/s12026-014-8566-4.
8
Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results from a 2-year prospective study.抗环瓜氨酸肽抗体滴度可预测未分化关节炎患者类风湿关节炎发病时间:一项为期2年的前瞻性研究结果
Arthritis Res Ther. 2013 Jan 22;15(1):R16. doi: 10.1186/ar4148.